Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety
NCT ID: NCT00960830
Last Updated: 2009-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2007-04-30
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU
NCT02888028
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
NCT01040988
REmote Web Assisted Care for Heart Failure Patients With Implantable Cardioverter Defibrillators
NCT01589913
Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (ICDs) With Enhanced SVT Discriminators
NCT01963286
Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients
NCT01230073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mirtazapine
mirtazapine
mirtazapine 15 mg daily tablets
mirtazapine
15 mg daily
mirtazapine, sugar pill
mirtazapine
15 mg daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mirtazapine
mirtazapine 15 mg daily tablets
mirtazapine
15 mg daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* depression
* anxiety
Exclusion Criteria
* other diseases reducing physical fitness
65 Years
87 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Nacional de Rosario
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
facultad de psicologia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
daniel jl serrani, MD
Role: PRINCIPAL_INVESTIGATOR
facultad de psicologia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cl Sn Nicol
San Nicolás, Bs As, Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS990
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.